Friday, June 10, 2022

< + > Baby Formula Blues: The Latest Regulatory Fiasco Reveals Problems Bigger Than The Recall Itself

As it is, infant formula is very difficult to manufacture and to keep compliant with FDA standards. The industry recognized the implications of the shutdown of the Abbott Nutrition plant and yet the FDA and the White House failed to connect on the issue.

No comments:

Post a Comment

< + > What's behind EHR-induced clinician burnout? And how to solve it?

When evaluating electronic health record systems to minimize documentation burden, usability is always the big challenge, says one informati...